Tumor Necrosis Factor Receptor 1, Soluble (sTNFR1) (Biotin)
Cat# MBS628017-5x0,05mg
Size : 5x0.05mg
Brand : MyBiosource
Tumor Necrosis Factor Receptor 1, Soluble (TNFRSF1A) Antibody – Rabbit Polyclonal
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS628017MBS628017 is an antibody targeting TNFRSF1A. Also known as Tumor Necrosis Factor Receptor 1, Soluble (sTNFR1) (Biotin). Reactive in Human. Host: Rabbit. More details
Product Overview
Online Datasheet in PDFProduct Name
Tumor Necrosis Factor Receptor 1, Soluble (TNFRSF1A), Polyclonal Antibody
Full Product Name
Tumor Necrosis Factor Receptor 1, Soluble (sTNFR1) (Biotin)
Product Gene Name
anti-TNFRSF1A antibody
Product Synonym Names
Anti -Tumor Necrosis Factor Receptor 1, Soluble (sTNFR1) (Biotin)
Clonality
Polyclonal
Isotype
IgG
Host
Rabbit
Species Reactivity
Human
Form/Format
Supplied as a lyophilized powder from a sterile-filtered solution in PBS, pH 7.4.
Purity/Purification
Affinity Purified
Purified by antigen affinity chromatography. Conjugated with biotin and remaining free biotin removed.
Purified by antigen affinity chromatography. Conjugated with biotin and remaining free biotin removed.
Specificity
Recognizes Tumor Necrosis Factor Receptor soluble (sTNF-receptor) (Biotin)
Preparation and Storage
-20 degree C
Molecular Weight
50,495 Da
Chromosome Location
Chromosome: 12; NC_000012.11 (6437923..6451283, complement). Location: 12p13.2
OMIM
142680
Immunogen
Tumor Necrosis Factor Receptor Soluble (sTNFr)
Country of Origin
USA
Reconstitution
The biotinylated antibody should be reconstituted to a concentration of 50ug/ml with sterile PBS solution containing 0.1% BSA. This solution can be stored at 4 degree C for at least one month without detectable loss of activity. Frozen aliquots of this solution are stable for at least 6 months when kept at- 20 degree C. Avoid more than one freeze-thaw cycle.
Product Categories/Family for anti-TNFRSF1A antibody
Antibodies; Abs to Receptors
Applications Tested/Suitable for anti-TNFRSF1A antibody
ELISA (EL/EIA), Western Blot (WB), Neutralization
Application Notes for anti-TNFRSF1A antibody
Neutralization
ELISA: To detect hsTNF-Receptor by direct ELISA (using 100 µl/well antibody solution) this antibody can be used at a concentration of 0.15-0.30ug/ml. Used in conjunction with compatible secondary reagents, allows the detection of at least 0.2ng/well of recombinant hsTNF-Receptor.
Western Blot: To detect hsTNF-Receptor by Western Blot analysis this antibody can be used at a concentration of 0.1-0.2 ug/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant hsTNF-Receptor is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions.
ELISA: To detect hsTNF-Receptor by direct ELISA (using 100 µl/well antibody solution) this antibody can be used at a concentration of 0.15-0.30ug/ml. Used in conjunction with compatible secondary reagents, allows the detection of at least 0.2ng/well of recombinant hsTNF-Receptor.
Western Blot: To detect hsTNF-Receptor by Western Blot analysis this antibody can be used at a concentration of 0.1-0.2 ug/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant hsTNF-Receptor is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions.
Other Notes
Small volumes of anti-TNFRSF1A antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for TNFRSF1A. It may not necessarily be applicable to this product.
NCBI Official Full Name
tumor necrosis factor receptor 1
NCBI Official Synonym Full Names
tumor necrosis factor receptor superfamily, member 1A
NCBI Official Symbol
TNFRSF1A
NCBI Official Synonym Symbols
FPF; p55; p60; TBP1; TNF-R; TNFAR; TNFR1; p55-R; CD120a; TNFR55; TNFR60; TNF-R-I; TNF-R55; MGC19588
UniProt Protein Name
Tumor necrosis factor receptor superfamily member 1A
UniProt Synonym Protein Names
Tumor necrosis factor receptor 1; TNF-R1; Tumor necrosis factor receptor type I; TNF-RI; TNFR-I; p55; p60
Protein Family
Tumor necrosis factor receptor superfamily
UniProt Gene Name
TNFRSF1A
UniProt Synonym Gene Names
TNFAR; TNFR1
UniProt Entry Name
TNR1A_HUMAN
NCBI Protein Information
tumor necrosis factor receptor superfamily member 1A; TNF-R1; TNF-RI; TNFR-I; OTTHUMP00000238438; OTTHUMP00000238440; OTTHUMP00000238441; tumor necrosis factor-alpha receptor; tumor necrosis factor receptor type 1; tumor necrosis factor binding protein 1; tumor necrosis factor receptor 1A isoform beta
NCBI Summary for TNFRSF1A
The protein encoded by this gene is a member of the TNF-receptor superfamily. This protein is one of the major receptors for the tumor necrosis factor-alpha. This receptor can activate NF-kappaB, mediate apoptosis, and function as a regulator of inflammation. Antiapoptotic protein BCL2-associated athanogene 4 (BAG4/SODD) and adaptor proteins TRADD and TRAF2 have been shown to interact with this receptor, and thus play regulatory roles in the signal transduction mediated by the receptor. Germline mutations of the extracellular domains of this receptor were found to be associated with the autosomal dominant periodic fever syndrome. The impaired receptor clearance is thought to be a mechanism of the disease. [provided by RefSeq]
Show more UniProt Comments for TNFRSF1A
TNF-R1: Receptor for TNFSF2/TNF-alpha and homotrimeric TNFSF1/lymphotoxin-alpha. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate- specific cysteine proteases) mediating apoptosis. Contributes to the induction of non-cytocidal TNF effects including anti-viral state and activation of the acid sphingomyelinase. Binding of TNF to the extracellular domain leads to homotrimerization. The aggregated death domains provide a novel molecular interface that interacts specifically with the death domain of TRADD. Various TRADD-interacting proteins such as TRAFS, RIPK1 and possibly FADD, are recruited to the complex by their association with TRADD. This complex activates at least two distinct signaling cascades, apoptosis and NF-kappa-B signaling. Interacts with BAG4, BRE, FEM1B, GRB2, SQSTM1 and TRPC4AP. Interacts with HCV core protein. Interacts with human cytomegalovirus/HHV-5 protein UL138. 3 isoforms of the human protein are produced by alternative splicing.
Protein type: Membrane protein, integral; Receptor, cytokine
Chromosomal Location of Human Ortholog: 12p13.2
Cellular Component: Golgi membrane; extracellular space; cell surface; mitochondrion; integral to plasma membrane; axon; plasma membrane; extracellular region; synapse; cytosol; nucleus; receptor complex; lipid raft
Molecular Function: protein binding; tumor necrosis factor receptor activity; protease binding; protein complex binding; tumor necrosis factor binding
Biological Process: response to alkaloid; viral reproduction; protein heterooligomerization; response to lipopolysaccharide; tumor necrosis factor-mediated signaling pathway; positive regulation of neuron apoptosis; negative regulation of interleukin-6 production; response to wounding; tetrapyrrole metabolic process; inflammatory response; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of protein import into nucleus, translocation; cytokine and chemokine mediated signaling pathway; response to amino acid stimulus; positive regulation of tumor necrosis factor production; prostaglandin metabolic process; positive regulation of tyrosine phosphorylation of Stat1 protein; positive regulation of angiogenesis; response to ethanol; induction of apoptosis via death domain receptors; DNA damage response, signal transduction resulting in induction of apoptosis; negative regulation of inflammatory response; defense response to bacterium; response to hypoxia; positive regulation of transcription from RNA polymerase II promoter; negative regulation of apoptosis; positive regulation of inflammatory response
Disease: Periodic Fever, Familial, Autosomal Dominant; Multiple Sclerosis, Susceptibility To, 5
Show more Protein type: Membrane protein, integral; Receptor, cytokine
Chromosomal Location of Human Ortholog: 12p13.2
Cellular Component: Golgi membrane; extracellular space; cell surface; mitochondrion; integral to plasma membrane; axon; plasma membrane; extracellular region; synapse; cytosol; nucleus; receptor complex; lipid raft
Molecular Function: protein binding; tumor necrosis factor receptor activity; protease binding; protein complex binding; tumor necrosis factor binding
Biological Process: response to alkaloid; viral reproduction; protein heterooligomerization; response to lipopolysaccharide; tumor necrosis factor-mediated signaling pathway; positive regulation of neuron apoptosis; negative regulation of interleukin-6 production; response to wounding; tetrapyrrole metabolic process; inflammatory response; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of protein import into nucleus, translocation; cytokine and chemokine mediated signaling pathway; response to amino acid stimulus; positive regulation of tumor necrosis factor production; prostaglandin metabolic process; positive regulation of tyrosine phosphorylation of Stat1 protein; positive regulation of angiogenesis; response to ethanol; induction of apoptosis via death domain receptors; DNA damage response, signal transduction resulting in induction of apoptosis; negative regulation of inflammatory response; defense response to bacterium; response to hypoxia; positive regulation of transcription from RNA polymerase II promoter; negative regulation of apoptosis; positive regulation of inflammatory response
Disease: Periodic Fever, Familial, Autosomal Dominant; Multiple Sclerosis, Susceptibility To, 5
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with anti-TNFRSF1A antibody
| Reference Product | PubMed Publications |
|---|---|
| TNF antibody | >302 publications with TNFRSF1A and TNF |
| TRADD antibody | >11 publications with TNFRSF1A and TRADD |
| IKBKB antibody | >8 publications with TNFRSF1A and IKBKB |
| TRAF2 antibody | >8 publications with TNFRSF1A and TRAF2 |
| RIPK1 antibody | >5 publications with TNFRSF1A and RIPK1 |
| LTA antibody | >5 publications with TNFRSF1A and LTA |
| JAK2 antibody | >4 publications with TNFRSF1A and JAK2 |
| CHUK antibody | >4 publications with TNFRSF1A and CHUK |
| TNFRSF25 antibody | >4 publications with TNFRSF1A and TNFRSF25 |
| MAPK1 antibody | >4 publications with TNFRSF1A and MAPK1 |
Pathways associated with anti-TNFRSF1A antibody
| Products by Pathway | Pathway Diagram |
|---|---|
| Adipocytokine Signaling Pathway antibodies | Adipocytokine Signaling Pathway Diagram |
| Adipocytokine Signaling Pathway antibodies | Adipocytokine Signaling Pathway Diagram |
| Alzheimer's Disease Pathway antibodies | Alzheimer's Disease Pathway Diagram |
| Alzheimer's Disease Pathway antibodies | Alzheimer's Disease Pathway Diagram |
| Amyotrophic Lateral Sclerosis (ALS) Pathway antibodies | Amyotrophic Lateral Sclerosis (ALS) Pathway Diagram |
| Amyotrophic Lateral Sclerosis (ALS) Pathway antibodies | Amyotrophic Lateral Sclerosis (ALS) Pathway Diagram |
| Apoptosis Pathway antibodies | Apoptosis Pathway Diagram |
| Apoptosis Pathway antibodies | Apoptosis Pathway Diagram |
| Apoptosis Pathway antibodies | Apoptosis Pathway Diagram |
| Apoptosis Pathway antibodies | Apoptosis Pathway Diagram |
Diseases associated with anti-TNFRSF1A antibody
| Disease Name | Pubmed Publications |
|---|---|
| Necrosis Antibodies | >363 publications with TNFRSF1A and Necrosis |
| Inflammation Antibodies | >118 publications with TNFRSF1A and Inflammation |
| Fever Antibodies | >106 publications with TNFRSF1A and Fever |
| Pain Antibodies | >42 publications with TNFRSF1A and Pain |
| Skin Diseases Antibodies | >37 publications with TNFRSF1A and Skin Diseases |
| Vascular Diseases Antibodies | >37 publications with TNFRSF1A and Vascular Diseases |
| Arthritis, Rheumatoid Antibodies | >24 publications with TNFRSF1A and Arthritis, Rheumatoid |
| Neoplasms Antibodies | >24 publications with TNFRSF1A and Neoplasms |
| Heart Diseases Antibodies | >23 publications with TNFRSF1A and Heart Diseases |
| Drug Toxicity Antibodies | >22 publications with TNFRSF1A and Drug Toxicity |
Organs/Tissues associated with anti-TNFRSF1A antibody
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Blood Antibodies | >132 publications with TNFRSF1A and Blood |
| Skin Antibodies | >36 publications with TNFRSF1A and Skin |
| Brain Antibodies | >31 publications with TNFRSF1A and Brain |
| Liver Antibodies | >30 publications with TNFRSF1A and Liver |
| Lung Antibodies | >20 publications with TNFRSF1A and Lung |
| Kidney Antibodies | >15 publications with TNFRSF1A and Kidney |
| Intestine Antibodies | >11 publications with TNFRSF1A and Intestine |
| Eye Antibodies | >9 publications with TNFRSF1A and Eye |
| Connective Tissue Antibodies | >8 publications with TNFRSF1A and Connective Tissue |
| Embryonic Tissue Antibodies | >5 publications with TNFRSF1A and Embryonic Tissue |


